Home › Stocks › Chemicals stocks › Navin Fluorine
Chemicals stocks Valuation research

Navin Fluorine fair value — specialty fluorine chemistry

Navin Fluorine makes refrigerant gases, specialty fluorine chemicals and custom molecules for global pharma and agrochemical companies.

FairStocks Research
Updated 15 Nov 2026 · 4 min read
| NSE: NAVINFLUOR ₹10,002
On this page ▾
  1. The business
  2. What the market assumes
  3. The ten-year record
  4. How it is valued
  5. What decides the value
  6. What could go wrong
  7. The full valuation
  8. Questions
Navin Fluorine (NAVINFLUOR) fair value — is it overvalued? Price ₹10,002, P/E 56.4, P/B 12.91, ROE —. Based on 10 years of reported financials. FairStocks.
Navin Fluorine at a glance. Share price, P/E, P/B and the ten-year revenue trend, from filed accounts. Updated 15 Nov 2026.
In 30 seconds

The market expects Navin Fluorine to do better than it ever has.

At today’s share price, buyers are assuming Navin Fluorine grows about 31% a year, forever. Over the last ten years it actually grew about 23% a year. So the share price only makes sense if the business improves on its own track record. If it simply carries on as before, buyers today have paid for something they will not get.

  • How it is valued: Discounted cash flow.
  • What the price assumes: 31% growth, against 23% the model takes from its own record.
  • Ten-year record: Between FY2019 and FY2026, Navin Fluorine's revenue went from ₹996 crore to ₹3,314 crore — it compounded at about 19% a year over 7 years.
  • Biggest swing factor: Specialty chemicals. Main risk: Customer concentration.
Price
₹10,002
Market cap
₹0.51L Cr
P/E
56.4
P/B
12.91
See Navin Fluorine's fair value and the full DCFEvery step of the Navin Fluorine working, the scenarios and the report Free during launch →

01A Mafatlal-group chemicals company

Navin Fluorine International, part of the Arvind Mafatlal group, makes inorganic fluorides, refrigerant gases, specialty fluorochemicals and intermediates, with plants at Surat, Dewas and Dahej.

Its contract development and manufacturing (CDMO) business makes molecules for global pharmaceutical and agrochemical innovators.

02What the market is assuming

Work backwards from today's share price and you can see what buyers are quietly taking for granted. Here is the growth that price implies for Navin Fluorine, next to what the model assumes from the company's own record.

Market expects
31%
growth priced into today's price
Model assumes
23%
growth the model assumes

The further apart these two numbers are, the bigger the bet a buyer at today's price is making.

03Navin Fluorine's record, in plain numbers

Between FY2019 and FY2026, Navin Fluorine's revenue went from ₹996 crore to ₹3,314 crore — it compounded at about 19% a year over 7 years. Net profit grew from ₹149 crore to ₹664 crore, about 24% a year — faster than revenue, so margins widened. In FY2026 it kept 20.0% of revenue as net profit — against a low of 12.3% in FY2025 and a high of 38.5% in FY2020. The latest year added 41.1% to revenue, well ahead of its own long-run pace.

Reading the record. FY2020's unusually high margin included one-time items; FY2026 profit jumped on stronger specialty and refrigerant demand.
Revenue₹0.01L → ₹0.03L Cr
181920212223242526
Earnings per share₹0.0 → ₹130.7
181920212223242526
Return on equity28.1% → 20.2%
1920212223242526
Debt to equity0.35 → 0.24
23242526

Revenue and earnings per share in ₹, return on equity and leverage as ratios — all from the filed statements.

Revenue and net profit by year (₹ crore)
YearRevenueNet profitMargin
FY201999614915.0%
FY20201,06240938.5%
FY20211,17925821.8%
FY20221,45326318.1%
FY20232,07737518.1%
FY20242,06527013.1%
FY20252,34928912.3%
FY20263,31466420.0%

04How Navin Fluorine gets valued — and why

Discounted cash flow

This business is valued on the cash it is expected to generate, discounted back at its cost of capital — with growth taken from its own ten-year record rather than from guidance.

05What decides Navin Fluorine's value

Specialty chemicals

Long contracts with global customers.

Refrigerants

New-generation refrigerant demand.

CDMO

Custom manufacturing for pharma and agrochemicals.

New capacity

Large investments need to fill up.

06What could go wrong

  • Customer concentration. A few contracts matter a lot.
  • Chinese competition. Pressure on chemical prices.
  • Agrochemical cycle. Destocking cuts orders.

07What the full Navin Fluorine valuation shows

Model value per share
₹0,000
Upside
+00%
Call
XXXX

Sign in free to see the complete Navin Fluorine valuation

  • ✓Fair value per share — from a ten-year discounted cash flow, every step shown
  • ✓The Workbench — change revenue growth, the discount rate or terminal growth and watch Navin Fluorine's value move
  • ✓Bull, base and bear cases — and exactly which assumptions move between them
  • ✓Peer comparison — against SRF, Gujarat Fluorochemicals and other chemicals makers
  • ✓Downloadable report — the full write-up, yours to keep
See Navin Fluorine's fair value and the full DCF — free
Free during launch · unlimited valuations · no card required

08Questions people ask about Navin Fluorine

What does Navin Fluorine make?

Refrigerants, inorganic fluorides, specialty fluorochemicals and custom molecules.

What is CDMO?

Contract development and manufacturing for other companies' products.

Navin Fluorine or SRF — what is the difference?

Both work with fluorine chemistry; SRF is larger and also makes films and textiles.

Is Navin Fluorine overvalued?

At ₹10,002 the market is pricing in roughly 31% sustained growth, against the ~23% its own record supports. That is more than it has delivered, so the price is justified only if the business can hold a rate it has not previously sustained.

What is the intrinsic value of Navin Fluorine?

It is computed from the filed financial statements using the method that fits this business (discounted cash flow), with every assumption shown alongside the result. The per-share figure and the full working are in the report.

How much debt does Navin Fluorine carry?

Debt to equity stands at 0.24, down from 0.35 at the start of the period — the balance sheet is a core input to the cost of capital used here.

About this research

Written by the FairStocks research team from Navin Fluorine's filed accounts and last reviewed 5 Oct 2026; the figures refresh as new results are filed. Every valuation uses the method that fits the business and shows its assumptions — see a fully worked example or the valuation guides. Educational research, not investment advice.

See Navin Fluorine's fair value and the full DCFUnlock free